Achieving greater transparency with no transparency

This is a preview of subscriber content

Subscribe now to continue reading.

The irony is that the committee considered the public summary document issue at its intracycle meeting in May this year. It was not included on any agenda and the first anyone heard of it was through informal mentions and when the outcomes were officially published in late June - so, achieving greater transparency with no transparency. …

Subscribe now to continue reading.

Achieving greater transparency with no transparency

This is a preview of subscriber content

Latest Video

Most Read

If this makes you uncomfortable, it should, because it is the only correct response

Merck welcomes new director of market access, government affairs and communications

Mark Butler acknowledges his concerns over potential impact of US pharmaceutical pricing reforms

Ipsen appoints Dagmar Tschoep as general manager for Australia and New Zealand

If the minister is too embarrassed to respond, it might be the best of bad responses

New Stories

If the minister is too embarrassed to respond, it might be the best of bad responses

Mark Butler acknowledges his concerns over potential impact of US pharmaceutical pricing reforms

CSL appoints new global head of search to accelerate innovation through strategic partnerships

Pharmacy Guild of Australia acquires Member Benefits Australia

Sanofi promotes a national dialogue on health literacy and trust

Island Pharmaceuticals reports breakthrough survival data for galidesivir in Marburg and Ebola studies

Australian Dementia Network Registry wants access to 'turning point' therapies

Sign In

Achieving greater transparency with no transparency

This is a preview of subscriber content

Latest Video

Most Read

If this makes you uncomfortable, it should, because it is the only correct response

Merck welcomes new director of market access, government affairs and communications

Mark Butler acknowledges his concerns over potential impact of US pharmaceutical pricing reforms

Ipsen appoints Dagmar Tschoep as general manager for Australia and New Zealand

If the minister is too embarrassed to respond, it might be the best of bad responses

Follow Us

New Stories

If the minister is too embarrassed to respond, it might be the best of bad responses

Mark Butler acknowledges his concerns over potential impact of US pharmaceutical pricing reforms

CSL appoints new global head of search to accelerate innovation through strategic partnerships

Pharmacy Guild of Australia acquires Member Benefits Australia

Sanofi promotes a national dialogue on health literacy and trust

Island Pharmaceuticals reports breakthrough survival data for galidesivir in Marburg and Ebola studies

Australian Dementia Network Registry wants access to 'turning point' therapies